Detalhe da pesquisa
1.
[Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids].
Zhonghua Gan Zang Bing Za Zhi
; 32(3): 268-272, 2024 Mar 20.
Artigo
em Zh
| MEDLINE | ID: mdl-38584113
2.
[Antiviral therapy for chronic hepatitis B: the imperative to move from scaling-up treatment to full treatment].
Zhonghua Gan Zang Bing Za Zhi
; 31(3): 225-227, 2023 Mar 20.
Artigo
em Zh
| MEDLINE | ID: mdl-37137844
3.
[Clinical efficacy analysis of TMF for the treatment of hyperviremia HBeAg-positive chronic hepatitis B patients with incomplete response to first-line oral antiviral nucleos(t)ide analogues].
Zhonghua Gan Zang Bing Za Zhi
; 31(3): 252-257, 2023 Mar 20.
Artigo
em Zh
| MEDLINE | ID: mdl-37137850
4.
[Clinical application of serum Golgi protein 73 in patients with chronic liver diseases].
Zhonghua Gan Zang Bing Za Zhi
; 30(1): 4-8, 2022 Jan 20.
Artigo
em Zh
| MEDLINE | ID: mdl-35152664
5.
[Special liver disease in adult: rare, complicated, and new understanding].
Zhonghua Gan Zang Bing Za Zhi
; 29(10): 913-914, 2021 Oct 20.
Artigo
em Zh
| MEDLINE | ID: mdl-34814382
6.
[Oral nucleos(t)ide analogues antiviral therapy reduces HBV-related HCC: consensus and contention].
Zhonghua Gan Zang Bing Za Zhi
; 29(4): 293-296, 2021 Apr 20.
Artigo
em Zh
| MEDLINE | ID: mdl-33979951
7.
[Early-stage clinical features, diagnosis and treatment progress of pregnancy-related liver disease].
Zhonghua Gan Zang Bing Za Zhi
; 29(10): 923-926, 2021 Oct 20.
Artigo
em Zh
| MEDLINE | ID: mdl-34814385
8.
[Analysis of clinical characteristics of patients with hyperthyroidism combined with liver injury].
Zhonghua Gan Zang Bing Za Zhi
; 29(10): 967-971, 2021 Oct 20.
Artigo
em Zh
| MEDLINE | ID: mdl-34814390
9.
[Optimal timing significance and clinical implications for the treatment of chronic HBV-infected patients with normal ALT].
Zhonghua Gan Zang Bing Za Zhi
; 28(12): 985-987, 2020 Dec 20.
Artigo
em Zh
| MEDLINE | ID: mdl-34865342
10.
[Study on early predictive factors of an incomplete viral response with 48 week-entecavir therapy in HBeAg-positive chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 28(12): 1008-1012, 2020 Dec 20.
Artigo
em Zh
| MEDLINE | ID: mdl-34865347
11.
[Aldo-keto reductase family 1 B10 participates in the regulation of hepatoma cell cycle through p27/p-Rb signaling pathway].
Zhonghua Gan Zang Bing Za Zhi
; 28(10): 861-867, 2020 Oct 20.
Artigo
em Zh
| MEDLINE | ID: mdl-33105932
12.
[Re-recognition of occult hepatitis B virus infection].
Zhonghua Yu Fang Yi Xue Za Zhi
; 53(5): 445-449, 2019 May 06.
Artigo
em Zh
| MEDLINE | ID: mdl-31091598
13.
[Considerations of using oral nucleos(t)ide analogues to interrupt mother-to-child transmission in HBV carrier pregnant woman with high viral load].
Zhonghua Gan Zang Bing Za Zhi
; 27(2): 85-87, 2019 Feb 20.
Artigo
em Zh
| MEDLINE | ID: mdl-30818909
14.
[Timing and selection of antiviral therapy with nucleos(t)ide analogues for prevention of hepatitis B virus-related HCC].
Zhonghua Gan Zang Bing Za Zhi
; 27(11): 827-830, 2019 Nov 20.
Artigo
em Zh
| MEDLINE | ID: mdl-31941235
15.
[Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
Zhonghua Gan Zang Bing Za Zhi
; 27(2): 106-111, 2019 Feb 20.
Artigo
em Zh
| MEDLINE | ID: mdl-30818914
16.
[Progress on the research of liver diseases in 2023].
Zhonghua Gan Zang Bing Za Zhi
; 32(1): 3-15, 2024 Jan 20.
Artigo
em Zh
| MEDLINE | ID: mdl-38320785
17.
[AKR1B10 inhibitor enhances the inhibitory effect of sorafenib on liver cancer xenograft].
Zhonghua Gan Zang Bing Za Zhi
; 27(1): 39-44, 2019 Jan 20.
Artigo
em Zh
| MEDLINE | ID: mdl-30685922
18.
[Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge].
Zhonghua Gan Zang Bing Za Zhi
; 26(4): 262-265, 2018 Apr 20.
Artigo
em Zh
| MEDLINE | ID: mdl-29996336
19.
[Progress on the research of liver diseases in 2022].
Zhonghua Gan Zang Bing Za Zhi
; 31(1): 3-15, 2023 Jan 20.
Artigo
em Zh
| MEDLINE | ID: mdl-36948845
20.
[HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study].
Zhonghua Gan Zang Bing Za Zhi
; 26(10): 756-764, 2018 Oct 20.
Artigo
em Zh
| MEDLINE | ID: mdl-30481882